Latest filing published 07 Nov 2025 for Ionis Pharmaceuticals INC, €45k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Richard S. Geary: trading record in brief
Richard S. Geary (senior executive) discloses dealings in Ionis Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 1 January 2009 to 6 November 2025, the count stands at 235 filings.
Every open-market trade on record is a sale: 107 sales worth €27.1M. Outside the open market, there are 7 share grants and 89 option exercises. 2025 to date brings no purchases and 16 sales.
Most recently, on 7 November 2025, the filings show an option exercise worth €45k in Ionis Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard S. Geary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 905 shares@ US$56.780.1% of flowCommon StockSEC:0000874015-25-000276:2
- 801 shares@ US$75.010.2% of flowCommon StockSEC:0000874015-25-000277:3
- 800 shares@ US$75.010.2% of flowCommon StockSEC:0000874015-25-000277:1
- 801 shares@ US$60.890.1% of flowCommon StockSEC:0000874015-25-000277:2
- 14,738 shares@ US$56.782.2% of flowCommon StockSEC:0000874015-25-000277:4
- 14,738 shares@ US$76.102.9% of flowCommon StockSEC:0000874015-25-000277:5
- 18,300 shares@ US$60.892.9% of flowCommon StockSEC:0000874015-25-000277:6
- 18,300 shares@ US$75.423.6% of flowCommon StockSEC:0000874015-25-000277:7
- 800 shares@ US$56.780.6% of flowCommon StockSEC:0000874015-25-000277:0
- 775 shares@ US$60.890.7% of flowCommon StockSEC:0000874015-25-000276:0
- 34,585 shares@ US$75.116.7% of flowCommon StockSEC:0000874015-25-000270:1
- 34,664 shares@ US$56.785.1% of flowCommon StockSEC:0000874015-25-000270:2
- 34,664 shares@ US$75.116.7% of flowCommon StockSEC:0000874015-25-000270:3
- 20,000 shares@ US$75.113.9% of flowCommon StockSEC:0000874015-25-000270:4
- 775 shares@ US$56.780.1% of flowCommon StockSEC:0000874015-25-000270:5
- 775 shares@ US$75.050.2% of flowCommon StockSEC:0000874015-25-000270:6
- 905 shares@ US$60.890.1% of flowCommon StockSEC:0000874015-25-000270:7
- 905 shares@ US$75.050.2% of flowCommon StockSEC:0000874015-25-000270:8
- 34,585 shares@ US$60.8929.3% of flowCommon StockSEC:0000874015-25-000270:0
- 57,900 shares@ US$65.249.6% of flowCommon StockSEC:0000874015-25-000239:1
- 57,900 shares@ US$53.7742.8% of flowCommon StockSEC:0000874015-25-000239:0
- 10,000 shares@ US$50.36717.0% of flowCommon StockSEC:0000874015-25-000218:0
- 165 shares@ US$27.710.1% of flowCommon StockSEC:0000874015-25-000190:0
- 10,000 shares@ US$42.85936.0% of flowCommon StockSEC:0000874015-25-000174:0
- 415 shares@ US$28.21150.2% of flowCommon StockSEC:0000874015-25-000100:0
25 of 231 declarations
